FRDD

Forensically-Relevant Drug Database

NPS Discovery

Dihydro-7-Hydroxy Mitragynine

Description

Preferred Drug Name

Dihydro-7-Hydroxy Mitragynine

Brief Description

Dihydro-7-hydroxy mitragynine (“MGM-15”) is synthetic derivative of 7-hydroxy mitragynine. It is structurally similar to known kratom alkaloids and is the primary component in products being sold as “MGM-15”.1 Analysis of dihydro-7-hydroxy mitragynine is challenging due to the analytical conversion of dihydro-7-hydroxy mitragynine to mitragynine during GC-MS analysis. Dihydro-7-hydroxy mitragynine was first identified by our laboratory in September 2025 and confirmed after acquiring standard reference material.

Structure


Nomenclature

Formal Name (IUPAC)

methyl (E)-2-(3-ethyl-7a-hydroxy-8-methoxy-2,3,4,6,7,12,12a,12b-octahydro-1H-indolo[2,3-a] quinolizin-2-yl)-3-methoxy-prop-2-enoate

Synonyms

DH7OH MG, Dihydro-7-OH Mitragynine, MGM-15

Identifiers

CAS Numbers

1158901-38-2

Chemistry

Chemical Formula

C23H32N2O5

Molecular Mass

416.50

Molecular Ion

416

Exact Mass

417.2384

SMILES

COC(/C([C@H]([C@@H](CN1CC[C@@]2(C3=C(N[C@]42[H])C=CC=C3OC)O)CC)C[C@]14[H])=C/OC)=O

InChI String

InChI=1S/C23H32N2O5/c1-5-14-12-25-10-9-23(27)20-17(7-6-8-19(20)29-3)24-21(23)18(25)11-15(14)16(13-28-2)22(26)30-4/h6-8,13-15,18,21,24,27H,5,9-12H2,1-4H3/b16-13+/t14-,15+,18+,21-,23+/m1/s1

InChI Key

QXFXDJATKPXTFF-DTQAZKPQSA-N

Classifications

Drug Class

Miscellaneous

Structural Classes

Indole (-ICA), Kratom Alkaloid

Drug Types

Metabolite

HRMS Analytics

Lab

CFSRE (Willow Grove, PA)

Comments

Sample Preparation:

Toxicology Samples: Liquid-liquid extraction

Drug Materials: Dilution of sample in mobile phase

Instrument:

Sciex TripleTOF® 5600+, Shimadzu Nexera XR UHPLC

Sciex X500R, Sciex ExionLC

Column:Phenomenex® Kinetex C18 (50 mm x 3.0 mm, 2.6 µm)
Mobile Phase:

A: Ammonium formate (10 mM, pH 3.0)

B: Methanol/acetonitrile (50:50)

Flow rate: 0.4 mL/min

Gradient:Initial: 95A:5B; 5A:95B over 13 min; 95A:5B at 15.5 min
Temperatures:

Autosampler: 15 °C

Column Oven: 30 °C

Source Heater: 600 °C

Injection Parameters:Injection Volume: 10 µL
QTOF Parameters:

TOF MS Scan Range: 100-510 Da

Precursor Isolation: SWATH® acquisition (27 windows)

Fragmentation: Collison Energy Spread (35±15 eV)

MS/MS Scan Range: 50-510 Da

 

Images

Fragments

417.2364
385.2105
252.1592
174.0912

Drug Origins and Uses

Drug Origins and Uses

Illicit, Semi-Synthetic

Biological Effects

Biological Effects

Analgesic, Depressant, Sedative/Hypnotic

Target Receptor or Neurotransmitter

Target Receptor or Neurotransmitter

MOR

Pharmacodynamics

Pharmacodynamics

Agonist

Toxicology Data Clinical Nonfatal

Source

Drug Testing and Analysis

Title

From Kratom to Semi-Synthetic Opioids: The Rise and Risks of MGM-15

Reference Link


Drug Control

US Controlled Substance Schedule

Not Controlled


Pharmacology Literature

Source

Current Drug Targets

Title

A Review on the Antinociceptive Effects of Mitragyna speciosa and Its Derivatives on Animal Model

Reference Link


Analytical Literature

Source

Drug Testing and Analysis

Title

From Kratom to Semi-Synthetic Opioids: The Rise and Risks of MGM-15

Reference Link


Published September 24, 2026